… Patients with MSI-H and aberrant p53 showed the worst survival … impact of p53 in GC differs
according to tumor localization and CTx. Altered p53 is characteristic for MSI-L, and the p53 …

… the prognosis of patients with BCLM and focused on prognosis prediction for these …
Interestingly, ESR1 and TP53 were the most mutually exclusive mutant gene pair in LMs (pairwise …

… So, aim of this study is to find out role of p53 overexpression in breast carcinoma and its …
impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis…

… in improvements in the ability to predict a patient’s risk of BC … clinicians in tailoring
treatment decisions for patients at the individual level. Nevertheless, despite the positive results …

… effective tool to predict the course of metastatic breast cancer (MBC… ctDNA to evaluate the
impact of cancer driven mutations on the … showing that breast cancer patients with TP53 mutant …

… treatment for advanced disease. We describe here the molecular landscape of metastatic
breast cancer … Private mutations in metastasis in more than two patients were detected in TP53, …

… These include using imprecise methods to determine tumor TP53 status and using different
clinical endpoints to assess predictive or prognostic significance of TP53 mutations. Perhaps …

… of function mutant p53 promotes cancer cell motility, invasion, and metastasis. … p53 that
foster metastasis in different types of cancers. We also discuss the prognostic value of mutant p53 …

… Concordant with our findings, they also found a significant association of p53 expression with
… p53 positivity was predictive of outcome in breast cancer patients with visceral metastasis […

… to evaluate whether they have a prognostic impact on patients’ survival. This analysis …
patients (TP53, PIK3CA, GATA3, ESR1, KMT2C, and CDH1). We observed that patients with TP53 …